Vasorelaxing effects of flavonoids: Investigation on the possible involvement of potassium channels

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 370, Issue 4, 2004, Pages 290-298

  Calderone, Vincenzo ^a   Chericoni, Silvio ^a   Martinelli, Cinzia ^a   Testai, Lara ^a   Nardi, Antonio ^a   Morelli, Ivano ^a   Breschi, Maria Cristina ^a   Martinotti, Enrica ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ATP sensitive potassium channel; Calcium activated potassium channel; Flavanone; Flavone; Flavonoid; Vasorelaxing effect

Indexed keywords

4' HYDROXYFLAVANONE; 5 METHOXYFLAVONE; 7 HYDROXYFLAVANONE; ACACETIN; ADENOSINE TRIPHOSPHATE; APIGENIN; BAICALEIN; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHRYSIN; FLAVANOID; FLAVONE DERIVATIVE; GLIBENCLAMIDE; HESPERIDIN; IBERIOTOXIN; LUTEOLIN; PINOCEMBRINE; POTASSIUM; PRIMULETIN; QUERCETIN DERIVATIVE; QUERCITRIN; RHOIFOLIN; TETRYLAMMONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; IN VITRO STUDY; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; MALE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; VASODILATION;

EID: 11244309512     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0964-z     Document Type: Article

References (24)

1. Aviram M, Fuhrman B (1998) Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 137:845-850
2. + channel opener induced relaxation of the porcine coronary artery. Naunyn-Schmiedebergs Arch Pharmacol 352:213-221
3. + channels: function, pharmacology and drugs. Curr Med Chem 9:1385-1395
4. Calderone V, Chericoni S, Testai L, Morelli I, Martinotti E (2001) Role of potassium channels in the vasodilatator response of flavonoids naringine and naringenine. Congress of the Italian Society of Pharmacology, Taormina, 26th October, p 25
5. Cavero I, Djellas Y, Guillon JM (1995) Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels. Cardiovasc Drugs Ther 9:245-255
6. Chan EC, Woodman OL (1999) Enhanced role for the opening of potassium channels in relaxant responses to acetylcholine after myocardial ischaemia and reperfusion in dog coronary arteries. Br J Pharmacol 126:925-932
7. Clark SG, Fuchs LC (2000) BK(Ca) channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy. Am J Physiol Heart Circ Physiol 279:H2598-H2603
8. Cortes SF, Rezende BA, Corriu C, Medeiros IA, Teixeira MM, Lopes MJ, Lemos VS (2001) Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteries. Br J Pharmacol 133:849-858
9. Duarte J, Vizcaíno FP, Utrilla P, Jiménez J, Tamargo J, Zarzuelo A (1993) Vasodilatatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationship. Gen Pharmacol 24:857-862
10. Fitzpatrick DF, Hirschfield L, Coffey RG (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265:H774-H778
11. Herrera MD, Zarzuelo A, Jimenez J, Marhuenda E, Duarte J (1996) Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen Pharmacol 27:273-277
12. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011
13. Knekt P, Jarvinen R, Reunanen A, Maatela J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med 1312:478-481
14. 2+-dependent large-conductance potassium channels: pharmacophore search and physiological evaluation of flavonoids. Bioorg Med Chem Lett 7:759-762
15. 2+-dependent large-conductance potassium channels: symmetrical pharmacophore and electrophysiological evaluation of bisphenols. Bioorg Med Chem Lett 13:1437-1439
16. Loffler C, Quast U (1997) Pharmacological characterisation of the sulphonylurea receptor in rat isolated aorta. Br J Pharmacol 120:476-480
17. +channel openers, nitrate derivatives, salbutamol and papaverine, in rat aortic rings. Naunyn-Schmiedebergs Arch Pharmacol 358:452-463
18. ATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 24:213-266
19. + channels in coronary smooth muscle during aging. Circ Res 88:210-216
20. Nardi A, Calderone V, Chericoni S, Morelli I (2003) Natural modulators of large-conductance calcium-activated potassium channels. Planta Med 69:885-892
21. Rice-Evans C, Miller NJ, Paganga G (1997) Antioxidant properties of phenolic compounds. Trends Plant Sci 2:152-159
22. Sargent CA, Grover GJ, Antonaccio MJ, McCullough JR (1993) The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004. J Pharmacol Exp Ther 266:1422-1429
23. + channels by pinacidil in human umbilical vascular endothelial cells. Drug Dev Res 48:6-16
24. Zhang YH, Park YS, Kim TJ, Fang LH, Ahn HY, Hong JT, Kim Y, Lee CK, Yhun YP (2002) Endothelium-dependent vasorelaxant and antiproliferative effect of apigenin. Gen Pharmacol 35:1-7